Prolonged daily dosing beyond 12 weeks transitions naturally into maintenance protocols using 23 doses weekly, which thousands of users sustain year-round without reported tolerance or receptor desensitization
however, avoiding strenuous physical activity close to bedtime is frequently advised
doi: 10.2337/dc19-0749 Summary Keywords obesity, oral semaglutide, GLP-1 receptor agonist, efficacy, safety, real-world evidence, weight loss Citation Krajnc M, Kuhar N and Koceva A (2025) Oral semaglutide for the treatment of obesity: a retrospective real-world study
This is known as gastric emptying
Emergency signs include fever with abdominal pain, persistent vomiting, and jaundice (yellowing of skin or eyes), which require urgent imaging and evaluation
A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+lymphocytes into lesional atopic dermatitis skin